Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $82.86 USD
Change Today +0.08 / 0.10%
Volume 1.3M
MNK On Other Exchanges
New York
As of 4:15 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Christopher Trudeau

Chief Executive Officer, President, Director and Member of Portfolio Committee,Mallinckrodt Public Limited Company
AgeTotal Calculated CompensationThis person is connected to 41 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Mark Christopher Trudeau has been Chief Executive Officer and President at Mallinckrodt public limited company since June 2013. Mr. Trudeau was joined Covidien plc as Senior Vice President and President of Pharmaceuticals Segment in February 1, 2012. He was joined Covidien from Bayer HealthCare Pharmaceuticals LLC USA, the U.S. healthcare business of Bayer AG, where he served as Chief Executive Officer. He simultaneously served as President of Bayer HealthCare Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

Damastown Industrial Estate
Dublin, Co. Dublin 15


Phone: 353 1 880 8180
Fax: 353 1 820 7948

Board Members Memberships*

Chief Executive Officer, President, Director and Member of Portfolio Committee


Bachelor's Degree
University of Michigan
University of Michigan

Other Affiliations*

Annual Compensation*

Total Annual Compensation$905,769

Stock Options*

Restricted Stock Awards$2,208,460
All Other Compensation$98,173
Exercised Options55,245
Exercised Options Value$790,127
Unexercisable Options413,280
Unexercisable Options Value$18,740,763
Total Value of Options$19,530,890
Total Number of Options468,525

Total Compensation*

Total Annual Cash Compensation$2,853,942
Total Short Term Compensation$905,769
Other Long Term Compensation$2,306,633
Total Calculated Compensation$6,502,676
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNK:US $82.86 USD +0.08


David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
Rajat Rai Chief Executive Officer
Akorn, Inc.
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MALLINCKRODT PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at